Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting

被引:0
|
作者
Thomas M. Atkinson
Lauren J. Rogak
Narre Heon
Sean J. Ryan
Mary Shaw
Liora P. Stark
Antonia V. Bennett
Ethan Basch
Yuelin Li
机构
[1] Memorial Sloan Kettering Cancer Center,Department of Psychiatry and Behavioral Sciences
[2] Memorial Sloan Kettering Cancer Center,Department of Epidemiology and Biostatistics
[3] City University of New York,undefined
[4] University of North Carolina-Chapel Hill,undefined
关键词
Patient-reported outcomes; Adverse events; Clinical trials; Clinician–patient agreement; Item response theory; Neoplasms;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:735 / 743
页数:8
相关论文
共 50 条
  • [41] Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life
    Terpos, Evangelos
    Mikhael, Joseph
    Hajek, Roman
    Chari, Ajai
    Zweegman, Sonja
    Lee, Hans C.
    Mateos, Maria-Victoria
    Larocca, Alessandra
    Ramasamy, Karthik
    Kaiser, Martin
    Cook, Gordon
    Weisel, Katja C.
    Costello, Caitlin L.
    Elliott, Jennifer
    Palumbo, Antonio
    Usmani, Saad Z.
    BLOOD CANCER JOURNAL, 2021, 11 (02)
  • [42] Correlation between adverse event reports of hypothyroidism and clinical response in patients treated with vascular endothelial growth factor receptor inhibitors (VEGFR-I).
    Speranza, G.
    Rubinstein, L.
    Ivy, S. P.
    Harris, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] Differences between male and female patients with regard to baseline demographics and clinical outcomes in the Asymptomatic Cardiac Ischemia Pilot (ACIP) trial
    Frishman, WH
    Gomberg-Maitland, M
    Hirsch, H
    Catanese, J
    Furia-Palazzo, S
    Mueller, H
    Steingart, R
    Forman, S
    CLINICAL CARDIOLOGY, 1998, 21 (03) : 184 - 190
  • [44] Differences in skin test responses between minority and non-minority patients with mild asthma in a multicenter clinical trial.
    Lemanske, RF
    Sorkness, CA
    Kunselman, SJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 519 - 519
  • [45] Evaluating an Intervention to Improve Communication Between Oncology Clinicians and Patients With Life-Limiting Cancer: A Cluster Randomized Clinical Trial of the Serious Illness Care Program
    Paladino, Joanna
    Bernacki, Rachelle
    Neville, Bridget A.
    Kavanagh, Jane
    Miranda, Stephen P.
    Palmor, Marissa
    Lakin, Joshua
    Desai, Meghna
    Lamas, Daniela
    Sanders, Justin J.
    Gass, Jonathon
    Henrich, Natalie
    Lipsitz, Stuart
    Fromme, Erik
    Gawande, Atul A.
    Block, Susan D.
    JAMA ONCOLOGY, 2019, 5 (06) : 801 - 809
  • [46] Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective Study
    Vitale, Maria Giuseppa
    Pipitone, Stefania
    Venturelli, Marta
    Baldessari, Cinzia
    Porta, Camillo
    Iannuzzi, Federica
    Basso, Umberto
    Scagliarini, Sarah
    Zucali, Paolo Andrea
    Galli, Luca
    Rossetti, Sabrina
    Caserta, Claudia
    Bracarda, Sergio
    Iacovelli, Roberto
    Masini, Cristina
    Cortellini, Alessio
    Di Girolamo, Stefania
    Buti, Sebastiano
    Fornarini, Giuseppe
    Carrozza, Francesco
    Santoni, Matteo
    Caputo, Francesco
    Giaquinta, Stefania
    Balduzzi, Sara
    D'Amico, Roberto
    Vitale, Giovanna
    Mighali, Pasquale
    Sabbatini, Roberto
    CLINICAL GENITOURINARY CANCER, 2020, 18 (06) : 477 - 488
  • [47] SIMILARITIES AND DIFFERENCES BETWEEN PATIENTS INCLUDED AND EXCLUDED FROM A RANDOMIZED CLINICAL TRIAL OF VITAMIN D SUPPLEMENTATION FOR IMPROVING GLUCOSE TOLERANCE IN PREDIABETES
    Eisenberg, Y.
    Manickam, B.
    Kukreja, S. C.
    Akbar, A.
    Mohiuddin, H.
    Barengolts, E.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (04) : 790 - 790
  • [48] Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide
    Knudsen, Jakob Schollhammer
    Thomsen, Reimar Wernich
    Pottegard, Anton
    Knop, Filip Krag
    Sorensen, Henrik Toft
    DIABETES CARE, 2018, 41 (09) : E133 - E135
  • [49] DIFFERENCES BETWEEN JAKIS-NAIVE AND JAKIS-NOT NAIVE PATIENTS IN A REAL LIFE CLINICAL SETTING: DATA FROM AN PROSPECTIVE MULTICENTRIC ITALIAN STUDY.
    Larosa, M.
    Becciolini, A.
    Bravi, E.
    Camellino, D.
    Plate, I.
    Arrigoni, E.
    Ometto, F.
    Di Donato, E.
    Adorni, G.
    Lucchini, G.
    Santilli, D.
    Bezzi, A.
    Focherini, M. C.
    Mascella, F.
    Bruzzese, V.
    Scolieri, P.
    Parisi, S.
    Fusaro, E.
    Ditto, M. C.
    Ravagnani, V.
    Sandri, G.
    Salvarani, C.
    Priora, M.
    Paroli, M.
    Caccavale, R.
    Andracco, R.
    Mansueto, N.
    Colina, M.
    Reta, M.
    Addimanda, O.
    Lo Gullo, A.
    Visalli, E.
    Foti, R.
    Amato, G.
    De Lucia, F.
    Farina, A.
    Girelli, F.
    Del Medico, P.
    Colella, A. Molica
    Franchina, V.
    Colella, F. Molica
    Lumetti, F.
    Ianniello, A.
    Nucera, V.
    Vitetta, R.
    Fiorenza, A.
    Rovera, G.
    Volpe, A.
    Ferrero, G.
    Marchetta, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1377 - 1378
  • [50] Effect of a Patient and Clinician Communication-Priming Intervention on Patient-Reported Goals-of-Care Discussions Between Patients With Serious Illness and Clinicians A Randomized Clinical Trial
    Curtis, J. Randall
    Downey, Lois
    Back, Anthony L.
    Nielsen, Elizabeth L.
    Paul, Sudiptho
    Lahdya, Alexandria Z.
    Treece, Patsy D.
    Armstrong, Priscilla
    Peck, Ronald
    Engelberg, Ruth A.
    JAMA INTERNAL MEDICINE, 2018, 178 (07) : 930 - 940